Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
10/2005
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234117 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level
10/20/2005US20050234112 treatment of COPD (chronic obstructive pulmonary disease), inflammation; Betamimetics; long-lasting effect; potent; beta 2-adrenoreceptor; 4-[2-(1,1-dimethyl-3-[1,2,4]triazol-4-yl-propylamino)-1-hydroxy-ethyl]-2-hydroxymethyl-phenol
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234040 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/20/2005CA2562140A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005CA2561741A1 Processes and reagents for oligonucleotide synthesis and purification
10/20/2005CA2560954A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005CA2560314A1 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/20/2005CA2557721A1 Ion channel modulators
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585541A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1223564C Intermediate halo phenyl derivatives and their use in process for preparing pyrrole derivatives
10/18/2005CA2307581C Heterocyclic compounds having nos inhibiting action
10/18/2005CA2241632C Selective chlorination of a 1-(2-fluorophenyl)-1,2,4-triazole
10/13/2005WO2005095362A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
10/13/2005WO2005095351A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/13/2005CA2557402A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681793A Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681390A Crystal form II 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2, 4-dihydro-3H-1, 2, 4-triazole-3-thione
10/12/2005CN1680340A Novel triazolo pyrimidine compounds
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/06/2005US20050222427 Copper-catalysed ligation of azides and acetylenes
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222173 Triazolopyrimidines
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050221990 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581515A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/05/2005EP1581507A1 Benzamide inhibitors of the p2x7 receptor
10/05/2005EP1549623A4 Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
10/05/2005CN1678593A Microbiocidal (e.g. fungicidal) 1, 2, 3-triazole derivatives
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1221537C Epimino substituted benzene derivative
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/04/2005US6951948 Method for synthesis of substituted azole libraries
09/2005
09/29/2005WO2005090320A2 Triazole derivatives and method of using the same to treat hiv infections
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005058844A3 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
09/29/2005WO2004069196A3 Novel compounds
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/28/2005EP1578736A1 Mek inhibiting oxa- and thia-diazol-2-yl-phenylamine derivatives
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005CN1675322A Printing process using specified azo compounds
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/22/2005WO2005087750A1 Ion channel modulators
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/22/2005WO2005047270A3 Substituted triazoles as sodium channel blockers
09/22/2005US20050209294 Reacting alkali metal salt of 1,2,4-triazole with alpha-halo substituted tolunitrile in presence of dimethylformamide; intermediate in manufacture of 4,4'-[1H-1,2,4-triazol-1-ylmethylene]bisbenzonitrile (Letrozole); by-product inhibition, efficiency; treatment of hormone-dependent breast cancer
09/22/2005US20050209287 3-thio-4,5-disubstituted-4H-1,2,4-triazoles; Inhibiting RNase H activity, and RNA dependent DNA polymerase (RDDP) activity of HIV reverse transcriptase; 4-benzyl-3-(benzylthio)-5-(2-furyl)-4H-1,2,4-triazole for example; retrovirus-associated cancer; drug screeening
09/22/2005US20050209223 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
09/22/2005CA2558224A1 Ion channel modulators
09/22/2005CA2557779A1 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1671717A Azole derivatives as antifungal agents
09/21/2005CN1671673A Copper-catalysed ligation of azides and acetylenes
09/21/2005CN1671377A 1H-1, 2, 4-triazole-3-carboxamide derivatives as cannabinoid-CB receptor ligands
09/21/2005CN1671371A Combination of an aromatase inhibitor with a bisphosphonate
09/20/2005US6946555 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/15/2005WO2005085226A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005WO2005085181A1 Functional material comprising fluorine compound
09/15/2005WO2005055940A3 Novel m3 muscarinic acetylcholine receptor antagonists
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/09/2005WO2005082892A2 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005082866A2 Substituted 1, 2, 4- triazole derivatives as oxytocin antagonists
09/09/2005WO2005044192A3 Triazole compounds and uses related thereto
09/08/2005US20050197374 New long acting beta-2 agonists and their use as medicaments
09/08/2005DE102004005316A1 Verfahren zur Herstellung von ortho- und parasubstituierten aromatischen Azoverbindungen sowie anderen Azoverbindungen Process for the preparation of ortho- and para-substituted aromatic azo compounds and other azo compounds
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/07/2005CN1665793A Ionic liquids
09/07/2005CN1665500A Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
09/07/2005CN1217928C Heterocyclic compounds having NOS inhibitory activities
09/07/2005CN1217660C IL-8 receptor antagonists
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 178